Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_492e63654ca997facebe0f85571b0695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_008dfc31df5649ea50c78bcdb40b7ef4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cedeb35ff2c91920ad6ca08cb374225e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf9cca1469d3a0ef3a4d4c4d7af579fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_909f3a8e51a945ae823c9ee95d23fb6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1a7207ed2fb57db6d80f433455ca1e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e2671e098ee1fc5883f4aaafb7e8f99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_958fd4e38485da58939e695e99a48313 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-106 |
filingDate |
1989-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1997-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ff1c1e537b79ee8d4344ebc9a94185d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7b78737e55af3680b78bd3d9f4d92fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aeb4663b5e2019264f48ccd955667c86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5541fe17d4b688e52463b6068838f069 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce16e7d33fbad1d325ecec6451d68c27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a5b0080424b05569b893e97ebd722c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02a06fb2498ad5a59f357207995c4fc4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95ff76bb5f44f35a882d6cf21c33547c |
publicationDate |
1997-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2072240-C1 |
titleOfInvention |
Method for treating the cases of chronic otitis |
abstract |
FIELD: medicine. SUBSTANCE: method involves introducing gauze turunda wetted with 1 ml of pylastin water solution into the acoustic meatus precleared from pus and dried for 2-3 h. The treatment is repeated daily until pus secretion from ill ear ceases. The treatment course duration is 2-7 days. EFFECT: enhanced effectiveness of treatment course. 1 tbl |
priorityDate |
1989-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |